Citigroup’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.8K | Buy |
10,838
+7,199
| +198% | +$21.8K | ﹤0.01% | 4217 |
|
|
2025
Q1 | $15.5K | Sell |
3,639
-9,306
| -72% | -$39.6K | ﹤0.01% | 4361 |
|
|
2024
Q4 | $68.4K | Buy |
+12,945
| New | +$68.4K | ﹤0.01% | 4145 |
|
|
2021
Q3 | – | Sell |
-15
| Closed | – | – | 5476 |
|
|
2021
Q2 | $0 | Sell |
15
-242
| -94% | – | ﹤0.01% | 5627 |
|
|
2021
Q1 | $4K | Sell |
257
-457
| -64% | -$7.11K | ﹤0.01% | 5285 |
|
|
2020
Q4 | $17K | Buy |
714
+617
| +636% | +$14.7K | ﹤0.01% | 4709 |
|
|
2020
Q3 | $2K | Sell |
97
-161
| -62% | -$3.32K | ﹤0.01% | 4932 |
|
|
2020
Q2 | $8K | Sell |
258
-1,555
| -86% | -$48.2K | ﹤0.01% | 4719 |
|
|
2020
Q1 | $43K | Buy |
+1,813
| New | +$43K | ﹤0.01% | 3899 |
|
|
2016
Q4 | – | Sell |
-15
| Closed | -$6K | – | 4960 |
|
|
2016
Q3 | $6K | Hold |
15
| – | – | ﹤0.01% | 4607 |
|
|
2016
Q2 | $5K | Sell |
15
-134
| -90% | -$44.7K | ﹤0.01% | 4716 |
|
|
2016
Q1 | $46K | Buy |
149
+91
| +157% | +$28.1K | ﹤0.01% | 4308 |
|
|
2015
Q4 | $36K | Buy |
+58
| New | +$36K | ﹤0.01% | 4262 |
|
|
2015
Q3 | – | Sell |
-3
| Closed | -$2K | – | 5519 |
|
|
2015
Q2 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 5196 |
|